Endonovo Therapeutics Inc (ENDV)

[SpongeBobStockPants]

Good news..

https://www.google.com/amp/s/www.yahoo.com/amphtml/finance/news/biotech-companies-news-123000294.html


The global market for non-opioid pain treatment totaled $9.9 billion in 2017 and is estimated to reach $22.6 billion by 2022, growing at a CAGR of 18.0% for the period of 2017-2022. One company in the non-opioid pain treatment market, Endonovo Therapeutics, Inc. (ENDV) (Market Cap: $7.478M, Share Price: $0.0189), a commercial-stage developer of non-invasive wearable Electroceuticals™ Therapies, has developed a therapy that has shown to significantly reduce postoperative pain without the kinds of side effects of many other opioid alternatives. Their non-invasive easy to use ORTHOHALO™ device delivers targeted Pulsed ElectroMagnetic Field (tPEMF) therapies to reduce pain and enhance post-surgical recovery, naturally. Its patented non-pharmacologic process uses proprietary technology to reduce pain, swelling, and inflammation.


ENDV has formed a partnership with US Authentic Trading Company (USAT) to act as the exclusive partner to assist with facilitating a relationship between the Company and China. China has been dealing with opioids since the 1600s, all the way back to the Opium wars. This market, added to the already robust US market makes ENDV one of the most enticing opioid alternative options for investors.

ENDV’s non-invasive therapies are not limited to pain management. The company has several non-invasive products in development for different conditions. In fact, the company just announced the allowance for the patent application entitled Devices And Method For Treatment Of Degenerative Joint Diseases With Electromagnetic Fields by the U.S. Patent and Trademark Office. Endonovo will be including this technology under its WOUNDPULSE™brand.